NCT03986658View on ClinicalTrials.gov

Linear Asymmetric rTMS in Adolescent Treatment-Resistant Depression: Tolerability of Treatment Durations Ranging From Ten Days to One Day

NAUnknownINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

March 31, 2022

Primary Completion Date

October 31, 2022

Study Completion Date

December 31, 2022

Conditions
Treatment Resistant Depression
Interventions
DEVICE

Linear Asymmetric rTMS System

Linear Asymmetric rTMS System

Trial Locations (1)

K1H 8L1

Children's Hospital of Eastern Ontario, Ottawa

Sponsors

Lead Sponsor

NeuroQore Inc.
All Listed Sponsors
collaborator

Children's Hospital of Eastern Ontario

OTHER

lead

NeuroQore Inc.

INDUSTRY

NCT03986658 - Linear Asymmetric rTMS in Adolescent Treatment-Resistant Depression: Tolerability of Treatment Durations Ranging From Ten Days to One Day | Biotech Hunter | Biotech Hunter